Primary Hyperparathyroidism: Clinical Trials

2 trials for Primary Hyperparathyroidism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 2

Follow Primary Hyperparathyroidism: new trials by email Literature Review of Primary Hyperparathyroidism trials Research Report on Primary Hyperparathyroidism

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism
Phase 4RecruitingUniversity of Aarhus1402025-03-012026-10-01
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Calcitonin - Primary Hyperparathyroidism, Hypercalcemia
Phase 4RecruitingJoseph Sferra372019-05-292024-09-19

Narrower conditions

Hyperparathyroidism, Primary (2)  ·  Hypercalcemia (1)

Broader conditions

Endocrine System Diseases (2)  ·  Hyperparathyroidism (2)  ·  Parathyroid Diseases (2)  ·  Calcium Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Water-Electrolyte Imbalance (1)

Interventions

Calcitonin (1)  ·  Saline Waters (1)  ·  Zoledronic Acid (1)  ·  salmon calcitonin (1)

Sponsors

Joseph Sferra (1)  ·  University of Aarhus (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Joseph Sferra, MD (1)  ·  Lars Rejnmark, Professor (1)

NIH funding

2023 (1)